首页> 外文OA文献 >Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial

【2h】

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial

机译：来自肝脏肿瘤热敏脂质体的多柔美蛋白的超声触发靶向药物递送的安全性和可行性（TARDOX）：单中心，开放标签，阶段1试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Paul C Lyon; Michael D Gray; Christophoros Mannaris; Lisa K Folkes; Michael Stratford; Leticia Campo; Daniel Y F Chung; Shaun Scott; Mark Anderson; Robert Goldin; Robert Carlisle; Feng Wu; Mark R Middleton; Fergus V Gleeson; Constantin C Coussios;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial [J] . Lyon Paul C., Gray Michael D., Mannaris Christophoros, The lancet oncology . 2018,第8期

机译：来自肝脏肿瘤热敏脂质体的超声触发靶向药物递送的安全性和可行性（TARDOX）：单中心，开放标签，阶段1试验
2. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial [J] . Lyon Paul C., Gray Michael D., Mannaris Christophoros, The lancet oncology . 2018,第8期

机译：来自肝脏肿瘤热敏脂质体的超声触发靶向药物递送的安全性和可行性（TARDOX）：单中心，开放标签，阶段1试验
3. Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox?) using focused ultrasound in patients with liver tumours [J] . Constantin?C.?Coussios, Fergus?V.?Gleeson, Mark?R.?Middleton, Journal of Therapeutic Ultrasound . 2017,第1期

机译：TARDOX的临床试验方案：I期研究，旨在通过聚焦超声在肝肿瘤患者中靶向释放溶酶热敏感性脂质体阿霉素（ThermoDox？）
4. Thermosensitive Magnetic Liposomes for Dual Targeted Stimuli-Responsive Drug Delivery in Glioma Treatment [C] . Jyh-Ping Chen, Hao-Lung Hsu, Yu-Jen Lu Society for Biomaterials annual meeting and exposition . 2019

机译：热敏磁性脂质体在胶质瘤治疗中的双重靶向刺激反应性药物递送。
5. Optimum Formulation of Thermosensitive Liposome for Targeted Tumor Drug Delivery利用統計を見る [D] . Iga Katsumi 1992

机译：用于靶向肿瘤药物递送的热敏脂质体的最佳配方见用法统计
6. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre open-label phase 1 trial [O] . Paul C Lyon, Michael D Gray, Christophoros Mannaris, -1

机译：超声触发肝肿瘤中热敏感脂质体产生的阿霉素靶向药物的安全性和可行性（TARDOX）：单中心开放标签1期试验
7. Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours [O] . Paul C. Lyon, Lucy F. Griffiths, Jenni Lee, 2017

机译：塔拉多术的临床试验方案：研究肝脏肿瘤患者使用聚焦超声的终点释放靶释放液体释放的可行性的临床试验方案，探讨了肝脏超声 - 热敏性脂质体DOXORUBICIN（Thermodox®）的可行性

Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial

著录项

引文网络

相似文献

相关主题

期刊订阅